Switching from Apixaban to Dabigatran in an 87-Year-Old Female
Stop apixaban 2.5 mg and start dabigatran at the time of the next scheduled apixaban dose, using 110 mg twice daily if she meets age-based criteria or has bleeding risk factors, or 150 mg twice daily if renal function is adequate (CrCl >30 mL/min) and no contraindications exist 1, 2.
Critical First Step: Assess Renal Function
Before any switch, you must calculate creatinine clearance using the Cockcroft-Gault formula 2, 3. This is non-negotiable because:
- Dabigatran has 80% renal elimination versus apixaban's 25% 4, 2
- CKD-EPI equations significantly overestimate renal function in elderly patients and should not be used for dabigatran dosing 3
- The hazard ratio for hemorrhagic events is 2.32 when incorrect dosing occurs based on wrong renal function estimates 3
If CrCl is 15-30 mL/min: Use dabigatran 75 mg twice daily 5, 2
If CrCl is <15 mL/min or on dialysis:** Dabigatran is contraindicated 5, 2
**If CrCl is 30-50 mL/min:** Consider 110 mg twice daily, especially given her age 6, 7
**If CrCl is >50 mL/min: Standard dose is 150 mg twice daily, but 110 mg twice daily is reasonable at age ≥80 years 6, 7
Switching Protocol
The switch is straightforward: Discontinue apixaban and begin dabigatran at the time the next dose of apixaban would have been taken 1, 2. There is no washout period needed and no bridging anticoagulation required 1, 2.
Specific Timing Example:
- If her last apixaban 2.5 mg dose is at 8 PM tonight
- Start dabigatran (appropriate dose) at 8 AM tomorrow morning
- Continue dabigatran twice daily at 12-hour intervals 2
Dose Selection Algorithm for This 87-Year-Old
Start with 110 mg twice daily if ANY of the following apply 6, 7:
- Age ≥80 years (she meets this criterion)
- Concomitant verapamil use
- CrCl 30-50 mL/min
- History of gastritis, esophagitis, or GERD
- Other increased bleeding risk factors
Use 150 mg twice daily only if 2:
- CrCl >50 mL/min AND
- Age <80 years (she doesn't meet this) AND
- No bleeding risk factors AND
- High thromboembolic risk justifies higher dose
Given her age of 87 years alone, 110 mg twice daily is the appropriate starting dose 6, 7.
Critical Monitoring Requirements
Renal function must be reassessed 2:
- Before initiating dabigatran
- Periodically during treatment (at least annually, more frequently if clinical deterioration)
- Any time there's acute illness, dehydration, or medication changes
Discontinue dabigatran immediately if acute renal failure develops 2.
Important Caveats
Why This Switch May Be Problematic:
Dabigatran has higher GI bleeding risk than apixaban in patients ≥75 years 8. The gastrointestinal bleeding hazard ratio for dabigatran versus warfarin is 1.50, while apixaban is 1.39 6.
Dabigatran requires twice-daily dosing with strict 12-hour intervals 2, which may reduce adherence compared to once-daily alternatives.
If she's already on apixaban 2.5 mg (the reduced dose), she likely has ≥2 of the following 1:
- Age ≥80 years (confirmed at 87)
- Weight ≤60 kg
- Serum creatinine ≥1.5 mg/dL
This suggests she's already at higher bleeding risk, making dabigatran a potentially less favorable choice 8, 9.
Drug Interactions to Avoid:
If CrCl 30-50 mL/min, reduce dabigatran to 75 mg twice daily if taking 5, 2:
- Dronedarone
- Systemic ketoconazole
Avoid P-gp inhibitors entirely if CrCl <50 mL/min 2.
Administration Instructions
- Swallow capsules whole with full glass of water 2
- Never crush, chew, or open capsules (increases exposure significantly) 2
- Take with food if GI distress occurs 2
- If dose missed and >6 hours until next dose, take it; otherwise skip 2
Reconsider This Switch
Apixaban may actually be the superior choice for this patient 9, 10. The 2024 ESC guidelines and recent evidence suggest apixaban has the most favorable bleeding profile in elderly patients 7, 10. Unless there's a compelling reason (e.g., apixaban failure, specific drug interaction), maintaining apixaban 2.5 mg twice daily is likely safer than switching to dabigatran in an 87-year-old 9, 10.